Pak1 and RAC1 inhibition phenocopy the effects of HDACIs on pMLC levels. (A) Western blot performed on Meg-01 cells treated for 24 hours with 10μM of the PAK1 inhibitor WR PAK18 showing an increase in pMLC levels. (B) Western blot performed on Meg-01 cells transduced with a constitutively activate (CA Rac1) or dominant-negative (DN Rac1) Rac1, showing a decrease and increase, respectively, in pMLC levels compared with empty vector (murine stem cell virus [MSCV]) alone.